First Solar, Inc. (Nasdaq: FSLR) has named Joe Kishkill as Chief Commercial Officer.
Kishkill will have comprehensive leadership responsibility for Global Business Development, Sales and International Public Affairs, with a primary focus on sustainable growth in emerging markets. Reporting to Kishkill will be regional business development and global public affairs teams.
“Joe brings unparalleled expertise to this extremely critical role,” said First Solar Chief Executive Officer Jim Hughes. “I am confident that he can craft and lead a business development organization that will deliver on our near-term objectives and build a solid foundation for growth.”
Most recently, Kishkill was President – Eastern Hemisphere for Exterran, a global provider of natural gas, petroleum and water treatment production services. Prior to that, he led Exterran’s business in the Latin America region. He also served as Enron’s Chief Executive Officer for South America.
Kishkill earned an MBA from the Harvard Graduate School of Business Administration, and holds a BS in electrical engineering from Brown University.
About First Solar, Inc.
First Solar is a leading global provider of comprehensive photovoltaic (PV) solar systems which use its advanced module and system technology. The company’s integrated power plant solutions deliver an economically attractive alternative to fossil-fuel electricity generation today. From raw material sourcing through end-of-life module recycling, First Solar’s renewable energy systems protect and enhance the environment. For more information about First Solar, please visit www.firstsolar.com.
For First Solar Investors
This release contains forward-looking statements which are made pursuant to safe harbor provisions of the Private Securities Litigation Reform Act of 1995. These forward-looking statements include statements, among other things, concerning: our business strategy, including anticipated trends and developments in and management plans for our business and the markets in which we operate; future financial results, operating results, revenues, gross margin, operating expenses, products, projected costs, warranties, solar module efficiency and balance of systems (“BoS”) cost reduction roadmaps, restructuring, product reliability and capital expenditures; our ability to continue to reduce the cost per watt of our solar modules; our ability to reduce the costs to construct photovoltaic (“PV”) solar power systems; research and development programs and our ability to improve the conversion efficiency of our solar modules; sales and marketing initiatives; and competition. These forward-looking statements are often characterized by the use of words such as “estimate,” “expect,” “anticipate,” “project,” “plan,” “intend,” “believe,” “forecast,” “foresee,” “likely,” “may,” “should,” “goal,” “target,” “might,” “will,” “could,” “predict,” “continue” and the negative or plural of these words and other comparable terminology. Forward-looking statements are only predictions based on our current expectations and our projections about future events. You should not place undue reliance on these forward-looking statements. We undertake no obligation to update any of these forward-looking statements for any reason. These forward-looking statements involve known and unknown risks, uncertainties, and other factors that may cause our actual results, levels of activity, performance, or achievements to differ materially from those expressed or implied by these statements. These factors include, but are not limited to, the matters discussed in Item 1A: “Risk Factors,” of our Annual Report on Form 10-K for the year ended December 31, 2012, as updated and supplemented by risk factors included in our Prospectus dated June 12, 2013 filed with the SEC pursuant to Rule 424(b)(5) (the “Prospectus”), Quarterly Reports on Form 10-Q, Current Reports on Form 8-K and other reports filed with the SEC.
|Cempra, Inc. Names David Moore as Chief Commercial Officer to Manage Commercial Development and Launch of Solithromycin and Taksta(TM) (2014/1/7)|
|Chelsea Therapeutics Names Keith W. Schmidt Chief Commercial Officer (2014/1/30)|
|CASMED Names Brian Wagner as Chief Commercial Officer (2013/10/2)|
|First Solar Names Paul Kaleta as General Counsel (2014/2/20)|
|SPI Solar Appoints Charlotte Xi Interim Chief Financial Officer ()|
|Trina Solar Announces Appointment of New Chief Financial Officer (2013/12/11)|
|Measurement Specialties Announces Appointment of Joe Gleeson as Chief Operating Officer (2014/4/8)|
|Coach to Host First Quarter of Fiscal Year Earnings Call with Lew Frankfort, Chairman & CEO, Victor Luis, President & Chief Commercial Officer, Jane Nielsen, EVP & CFO, and Francine Della Badia, President, North America Retail (2013/10/15)|
|SouthGobi Resources Announces Resignation of Brett Salt as Non-Executive Director and His Appointment as Chief Commercial Officer ()|
|Sysco Strengthens Executive Leadership Roles; Tom Bene Named EVP and Chief Commercial Officer; Mike Green Named President of Foodservice Operations (2013/8/28)|
|Start Premium Trial||Register For Free|
|P||F||Fund Financial Data (13,000+ funds)|
|P||F||Stock Financial Data (7,000+ stocks)|
|P||F||Stock and Fund Screeners (basic)|
|P||F||Investing Articles and Market Commentary|
|P||F||Articles Archive (>30 days)|
|P||F||Discuss (dozens of stock, fund, bond, and general bulletin boards)|
|P||F||Portfolio Manager (basic)|
|P||F||Morningstar Investment Classroom|
|P||F||Access Your Portfolio Anytime, Anywhere via Your Mobile Device|
|P||Morningstar Fund Analyst Reports (full research on 1,700 funds, ETFs, and CEFs)|
|P||Morningstar Stock Analyst Reports (full research on more than 1,100 stocks)|
|P||Portfolio Manager (advanced with 10 X-Ray analyses, including recommendations)|
|P||Portfolio Monitor (monthly and on-demand personalized portfolio statements)|
|P||Morningstar Proprietary Stock Information (stock star ratings, buy/sell prices, economic moat ratings, and more)|
|P||Morningstar 5-Star Stock and Fund Favorites & Red Flags eNewsletters|
|P||Premium Stock and Fund Screeners (advanced with nearly infinite ways to find the best securities for you)|
|P||Discounts on Morningstar newsletters, books, seminars, and more|
Access these features and more when you sign up for Free Membership.
Join Morningstar today. It's Free.
Access these features and more when you sign up for Premium Membership.
Start your free 14-day trial today online
Your subscription may be tax deductible. Please contact your tax advisor.